Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Measles morbillivirus, Mumps orthorubulavirus, and Rubella virus are three distinct viral pathogens that are the causative agents of measles, mumps, and rubella, respectively (CDC, 2020). Measles and mumps are negative-sense single-stranded RNA viruses belonging to the Paramyxoviridae family, whereas Rubella virus is a positive-sense single-stranded RNA virus in the Matonaviridae family (StatPearls, 2023). These viruses are clinically grouped as a single target for the trivalent MMR vaccine, which utilizes live-attenuated strains to stimulate the production of neutralizing antibodies and cell-mediated immunity (FDA, 2020). Measles is highly contagious and can lead to severe complications such as pneumonia and encephalitis, while Rubella is particularly dangerous during pregnancy due to the risk of Congenital Rubella Syndrome (WHO, 2023). Because this entry combines three separate biological species into one entity, it is considered a vaccine target rather than a single molecular receptor or enzyme. Therapeutic management of active infections is primarily supportive, making preventative immunization the cornerstone of clinical intervention.
Induction of active immunity through the production of neutralizing antibodies and cell-mediated immune responses against measles, mumps, and rubella viral antigens (StatPearls, 2023).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Measles, Mumps, and Rubella Virus (MMR).